Insider trade

Zevra Therapeutics (ZVRA): CEO sold ~$246K

Neil F. Mcfarlane, CEO at Zevra Therapeutics, sold ~$246K of Zevra Therapeutics shares.

~$246K
Approx. value · 31K sh @ $8.05
192K
Holds after · shares reported
Traded
Feb 14, 2025
Filed
Feb 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 13, 2025Insider · 4 peopleInsiders: 4 sales (~$674K)
  2. Feb 14, 2025 · this disclosureInsiderCEO sold ~$246K of ZVRA shares in the open market

What came next

  1. Mar 19, 2025InsiderDirector purchased ~$80K of ZVRA shares in the open market
  2. Mar 28, 2025InsiderDirector purchased ~$2.4K of ZVRA shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Zevra Therapeutics

For Zevra Therapeutics, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZVRA page.

Other recent filings by Neil F. Mcfarlane, President and CEO

The full history of Neil F. Mcfarlane, President and CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which Zevra Therapeutics (ZVRA) insider traded, and how much?

Neil F. Mcfarlane, CEO at Zevra Therapeutics, sold ~$246K of Zevra Therapeutics shares. 31K shares at $8.05.

When did it happen, and when was it made public?

Traded: Feb 14, 2025. Filed: Feb 14, 2025.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Zevra Therapeutics recently?

For Zevra Therapeutics, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ZVRA page.

Does this mean ZVRA stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Zevra Therapeutics

Everything OQRO holds on this company is on its ZVRA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data